| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |